## DisclosureEquityIncentivePlansTables

**Year Ended**

|  | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
| --- | --- | --- | --- |
| **  Summary of Stock Option and RSU Activity** | The following table summarizes our stock option and RSU activity:

                                                          Weighted-             
Weighted-              
                                           Weighted-      Average               
Average                
                                           Average        Remaining             
Grant                  
                                           Exercise       Contractual           
Date Fair              
                                           Price          Life (years)          
Value                  
  Balance,                     31,208      $273.40                           
4,659      $              294.63  
  Granted                       1,473      $265.26                           
3,752      $              282.74  
  Exercised or released        (1,441      $106.68                          
(1,949      $              277.13  
  Cancelled                    (1,245      $310.57                          
(1,656      $              295.05  
  Balance,                     29,995      $279.49        6.89               
4,806      $              291.06  
  Vested and                   15,860      $228.29        6.05               
4,804      $              291.05  
  Exercisable and vested,       7,025      $94.07         3.39
 |  |  |
| **  Schedule of Fair Value of Stock Option Award and ESPP on Grant Date** | We use the fair value method in recognizing stock-based compensation expense. 
Under the fair value method, we estimate the fair value of each stock option 
award with service or service and performance conditions and the ESPP on the 
grant date generally using the Black-Scholes option pricing model and the 
weighted-average assumptions in the following table:

                                        Year Ended December 31,                 
                                        2019                                    
2018                  2017              
 ───────────────────────────────────────────────────────────────────────────────
──────────────────────────────────────────
  Risk-free interest rate:                                                      
  Stock options                                                         2.4     
2.5                   1.8  
  ESPP                                                                  2.2     
2.0                   1.1  
  Expected term (in years):                                                     
  Stock options                                                         4.5     
4.7                   5.1  
  ESPP                                                                  0.5     
0.5                   0.5  
  Expected volatility:                                                          
  Stock options                                                          48     
42                    42  
  ESPP                                                                   53     
43                    35  
  Dividend yield:                                                               
  Stock options                                                         0.0     
0.0                   0.0  
  ESPP                                                                  0.0     
0.0                   0.0  
  Grant date fair value per share:                                              
  Stock options                         $                            111.59     
$         121.92      $         122.25  
  ESPP                                  $                             78.25     
$          84.37      $          75.05
 |  |  |
| **  Summary of Operational Milestone Based on Revenue or Adjusted EBITDA** | Total Annualized Revenue      Annualized Adjusted EBITDA  
             (in billions)                                  
                                             (in billions)  
 ────────────────────────────────────────────────────────────
                     $20.0                            $1.5  
                     $35.0                            $3.0  
                     $55.0                            $4.5  
                     $75.0                            $6.0  
                    $100.0                            $8.0  
                    $125.0                           $10.0  
                    $150.0                           $12.0  
                   $ 175.0                           $14.0
 |  |  |
| **  Summary of Stock-Based Compensation Expense** | The following table summarizes our stock-based compensation expense by line item
in the consolidated statements of operations (in millions):

                                           Year Ended December 31,              
                                           2019                                 
2018               2017           
 ───────────────────────────────────────────────────────────────────────────────
────────────────────────────────────
  Cost of revenues                         $                            128     
$         109      $          64  
  Research and development                                              285     
261                218  
  Selling, general and administrative                                   482     
375                185  
  Restructuring and other                                                 3     
4                  —  
  Total                                    $                            898     
$         749      $         467
 |  |  |